辐射诱发恶心和呕吐的控制蓝图。讨论。 - Suppr

Suppr

超能文献

Blueprint for the control of radiation-induced nausea and vomiting. Discussion.

作者信息

Horiot Jean-Claude

机构信息

Centre de Lutte contre le Cancer G.F. Leclerc, Dijon, France.

出版信息

Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.

DOI:10.1080/11001700410016170

PMID:15370627

Abstract

摘要

相似文献

Blueprint for the control of radiation-induced nausea and vomiting. Discussion.

Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.

In search of the ideal antiemetic.

Acta Oncol. 2004 Sep;43 Suppl 15:13-8. doi: 10.1080/11001700410016152.

First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.

Acta Oncol. 2004 Sep;43 Suppl 15:19-22. doi: 10.1080/11001700410016161.

Current treatment patterns for radiation-induced nausea and vomiting.

Acta Oncol. 2004 Sep;43 Suppl 15:9-12. doi: 10.1080/11001700410016143.

Management of radiation-induced nausea and vomiting.

Exp Hematol. 2007 Apr;35(4 Suppl 1):34-6. doi: 10.1016/j.exphem.2007.01.010.

Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.

Can J Oncol. 1996 Feb;6 Suppl 1:17-22.

Optimising antiemetic therapy: what are the problems and how can they be overcome?

Curr Med Res Opin. 2005 Jun;21(6):885-97. doi: 10.1185/030079905X46313.

Blueprint for the control of radiation-induced nausea and vomiting. Introduction.

Acta Oncol. 2004 Sep;43 Suppl 15:3-4. doi: 10.1080/11001700410016125.

5-HT3-receptor antagonists in the control of delayed-onset emesis.

Anticancer Res. 2003 May-Jun;23(3C):2773-82.

Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?

Cancer Chemother Pharmacol. 2005 Sep;56(3):231-8. doi: 10.1007/s00280-005-1033-0. Epub 2005 Apr 19.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Blueprint for the control of radiation-induced nausea and vomiting. Discussion.

作者信息

Horiot Jean-Claude

机构信息

Centre de Lutte contre le Cancer G.F. Leclerc, Dijon, France.

出版信息

Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.

DOI:10.1080/11001700410016170

PMID:15370627

Abstract

摘要

相似文献

Blueprint for the control of radiation-induced nausea and vomiting. Discussion.

Acta Oncol. 2004 Sep;43 Suppl 15:23-4. doi: 10.1080/11001700410016170.

In search of the ideal antiemetic.

Acta Oncol. 2004 Sep;43 Suppl 15:13-8. doi: 10.1080/11001700410016152.

First choice for radiation-induced nausea and vomiting--the efficacy and safety of granisetron.

Acta Oncol. 2004 Sep;43 Suppl 15:19-22. doi: 10.1080/11001700410016161.

Current treatment patterns for radiation-induced nausea and vomiting.

Acta Oncol. 2004 Sep;43 Suppl 15:9-12. doi: 10.1080/11001700410016143.

Management of radiation-induced nausea and vomiting.

Exp Hematol. 2007 Apr;35(4 Suppl 1):34-6. doi: 10.1016/j.exphem.2007.01.010.

Controlling the toxicity of palliative radiotherapy: the role of 5-HT3 antagonists.

Can J Oncol. 1996 Feb;6 Suppl 1:17-22.

Optimising antiemetic therapy: what are the problems and how can they be overcome?

Curr Med Res Opin. 2005 Jun;21(6):885-97. doi: 10.1185/030079905X46313.

Blueprint for the control of radiation-induced nausea and vomiting. Introduction.

Acta Oncol. 2004 Sep;43 Suppl 15:3-4. doi: 10.1080/11001700410016125.

5-HT3-receptor antagonists in the control of delayed-onset emesis.

Anticancer Res. 2003 May-Jun;23(3C):2773-82.

Is there a pharmacological basis for differences in 5-HT3-receptor antagonist efficacy in refractory patients?

Cancer Chemother Pharmacol. 2005 Sep;56(3):231-8. doi: 10.1007/s00280-005-1033-0. Epub 2005 Apr 19.